Eating disorder, low protein intake
This treatment is not intended to diagnose, treat, cure, or prevent any medical conditions
These 3.8 million met the clinical criteria for the Bridge program, did not have a diagnosis of type 2 diabetes, sleep apnea or MASH, did not have a GLP-1 Part D covered prescription in 2023 and "could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026," the report added
This was not a randomized control trial, rather we recruited participants already taking these medications, additionally we did not use a placebo for alcohol administration
AHK-Cu appears to extend the anagen phase by keeping dermal papilla cells functional longer
It supports ovarian function and may indirectly reduce oxidative stress via hormonal homeostasis